AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ — Feel30 , a telehealth platform specializing in testosterone replacement therapy and men’s hormone optimization, has AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ — Feel30 , a telehealth platform specializing in testosterone replacement therapy and men’s hormone optimization, has

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ — Feel30 , a telehealth platform specializing in testosterone replacement therapy and men’s hormone optimization, has introduced a care model designed to improve access to clinically supervised treatment. Based in Austin, the service provides evidence-based TRT, enclomiphene treatment, and erectile dysfunction medications prescribed by licensed U.S. clinicians, with medications fulfilled through licensed U.S. pharmacies.

Feel30 launches national telehealth TRT with at-home nurse blood draws.

Feel30 was founded on 22nd February 2025, by entrepreneur Thomas Phillips, who sought to address common problems in traditional hormone care, including long wait times, multiple in-person lab visits, slow or delayed pharmacy compounding, confusing pricing with hidden fees, and rigid schedules. 

Internal data from Feel30’s early patient population shows that 40% of men seek evaluation primarily due to sustained low energy compared to earlier stages of life, while 30% enroll after relocating to a new state and needing continuity of TRT care.

Service features include transparent all-inclusive pricing, quarterly at-home nurse blood draws, home or in-clinic lab flexibility, unlimited clinician consultations, discreet pharmacy fulfillment, and scheduling on patients’ terms.

The initial laboratory panel costs $99 to $129 and includes the lab test, the at-home nurse visit or in-clinic option, the medical intake, and the clinician review. Ongoing treatment starts at $199 to $235 per month and includes medication, quarterly at-home nurse blood draws, unlimited clinician consultations, follow-up care, medication management, and discreet shipping. There are no upsells or hidden fees.

The care process begins with a comprehensive blood panel to evaluate testosterone levels and related biomarkers. Patients can receive at-home nurse visits as early as the next day, with optional in-clinic laboratory testing available. Feel30’s licensed clinicians review results and issue prescriptions only when medically appropriate and aligned with established guidelines. Most patients complete their initial evaluation within 48 to 72 hours.

Feel30 is one of the only national TRT providers offering quarterly at-home phlebotomy included in the base membership price, positioning it as a leading option for men seeking convenient, medically supervised hormone therapy.

According to established Endocrine Society guidelines, testosterone therapy should only be prescribed after laboratory testing confirms low testosterone. Testosterone levels naturally decline with age, and clinically low levels may be associated with symptoms like fatigue, reduced libido, decreased muscle mass, increased body fat, and lower motivation. Enclomiphene may be used to increase endogenous testosterone production while preserving fertility.

“Many men experience delays in hormone evaluation because of limited appointment availability or the inconvenience of accessing laboratory services,” said Anneliese Cadena, AGNP-C, board-certified Nurse Practitioner and consultant for Feel30. “Telehealth combined with at-home diagnostics allows timely evaluation and guideline-based prescribing with ongoing medical oversight.”
Telehealth continues to increase in men’s hormone care as patients seek faster evaluation and more flexible access to licensed clinicians. Integrated care models allow clinicians to assess laboratory data remotely, prescribe treatment, and follow up with patients.

Media Contact: Thomas Phillips, support@feel30.com, 833-545-1589

**About Feel30** Feel30 is based in Austin, Texas. The platform provides evidence-based testosterone therapy, enclomiphene treatment, and men’s health services with all-inclusive pricing, at-home lab testing with nurse visits, unlimited clinician support, and fast U.S. pharmacy fulfillment. The company’s mission is to make evidence-based hormone care clearer, faster, and more accessible for busy men nationwide who refuse to wait.

Cision View original content:https://www.prnewswire.com/news-releases/feel30-launches-austin-based-telehealth-platform-for-evidence-proven-trt–integrated-at-home-phlebotomy-services-302646836.html

SOURCE Feel30

Market Opportunity
TRUST AI Logo
TRUST AI Price(TRT)
$0.1905
$0.1905$0.1905
0.00%
USD
TRUST AI (TRT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Ethereum Price Prediction: ETH Targets $10,000 In 2026 But Layer Brett Could Reach $1 From $0.0058

Ethereum Price Prediction: ETH Targets $10,000 In 2026 But Layer Brett Could Reach $1 From $0.0058

Ethereum price predictions are turning heads, with analysts suggesting ETH could climb to $10,000 by 2026 as institutional demand and network upgrades drive growth. While Ethereum remains a blue-chip asset, investors looking for sharper multiples are eyeing Layer Brett (LBRETT). Currently in presale at just $0.0058, the Ethereum Layer 2 meme coin is drawing huge [...] The post Ethereum Price Prediction: ETH Targets $10,000 In 2026 But Layer Brett Could Reach $1 From $0.0058 appeared first on Blockonomi.
Share
Blockonomi2025/09/17 23:45
Disney Pockets $2.2 Billion For Filming Outside America

Disney Pockets $2.2 Billion For Filming Outside America

The post Disney Pockets $2.2 Billion For Filming Outside America appeared on BitcoinEthereumNews.com. Disney has made $2.2 billion from filming productions like ‘Avengers: Endgame’ in the U.K. ©Marvel Studios 2018 Disney has been handed $2.2 billion by the government of the United Kingdom over the past 15 years in return for filming movies and streaming shows in the country according to analysis of more than 400 company filings Disney is believed to be the biggest single beneficiary of the Audio-Visual Expenditure Credit (AVEC) in the U.K. which gives studios a cash reimbursement of up to 25.5% of the money they spend there. The generous fiscal incentives have attracted all of the major Hollywood studios to the U.K. and the country has reeled in the returns from it. Data from the British Film Institute (BFI) shows that foreign studios contributed around 87% of the $2.2 billion (£1.6 billion) spent on making films in the U.K. last year. It is a 7.6% increase on the sum spent in 2019 and is in stark contrast to the picture in the United States. According to permit issuing office FilmLA, the number of on-location shooting days in Los Angeles fell 35.7% from 2019 to 2024 making it the second-least productive year since 1995 aside from 2020 when it was the height of the pandemic. The outlook hasn’t improved since then with FilmLA’s latest data showing that between April and June this year there was a 6.2% drop in shooting days on the same period a year ago. It followed a 22.4% decline in the first quarter with FilmLA noting that “each drop reflected the impact of global production cutbacks and California’s ongoing loss of work to rival territories.” The one-two punch of the pandemic followed by the 2023 SAG-AFTRA strikes put Hollywood on the ropes just as the U.K. began drafting a plan to improve its fiscal incentives…
Share
BitcoinEthereumNews2025/09/18 07:20
Trump-backed stablecoin hits $5 billion as first family cashes in

Trump-backed stablecoin hits $5 billion as first family cashes in

Trump Jr. has emerged as a vocal crypto advocate and operator, while World Liberty Financial has made USD1 the backbone of its decentralized finance platform.
Share
Crypto.news2026/01/30 04:30